- Home
- CENX vs XENE Comparison
CENX vs XENE Comparison
Compare CENX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CENX | XENE |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Aluminum | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.2B |
| IPO Year | 2004 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CENX | XENE |
|---|---|---|
| Price | $46.72 | $62.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $65.67 | ★ $68.55 |
| AVG Volume (30 Days) | ★ 2.1M | 654.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.62 | N/A |
| Revenue | ★ $1,893,200,000.00 | $311,000.00 |
| Revenue This Year | $20.77 | N/A |
| Revenue Next Year | $14.58 | $2,496.48 |
| P/E Ratio | $8.25 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.92 | $35.60 |
| 52 Week High | $70.43 | $72.66 |
Technical Indicators
Market Signals| Indicator | CENX | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 45.39 |
| Support Level | $42.50 | $61.16 |
| Resistance Level | $48.28 | $62.91 |
| Average True Range (ATR) | 2.70 | 2.15 |
| MACD | 0.46 | -0.39 |
| Stochastic Oscillator | 37.79 | 19.72 |
Price Performance
Historical ComparisonAbout CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.